I, 5. Treatment of viral gastroenteritis

Bass, Dorsey

doi:10.1016/s0168-7069(03)09006-2

Cited by 3 publications

(2 citation statements)

References 59 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…There are no specific antiviral chemotherapeutic agents in clinical use. 15,16 Outbreaks of nosocomial rotavirus infections are common in children on hospital wards and in day-care centres. Outbreaks of diarrhoea and vomiting caused by noroviruses occur in children and adults following banquets, on cruise ships, and in cafeterias, schools, hotels and fast-food restaurants.…”

Section: Managementmentioning

confidence: 99%

Viral gastroenteritis

Desselberger¹,

Gray²

2009

Medicine

View full text Add to dashboard Cite

The virology, immunology, diagnosis, clinical symptoms, treatment, epidemiology and prevention measures relating to the most common viral causes of acute gastroenteritis (rotaviruses, human caliciviruses, astroviruses and enteric adenoviruses) are briefly reviewed. Uncommon viral causes of acute gastroenteritis and viruses causing gastroenteritis in immunodeficient patients are mentioned. The main change over the past three years has been the development, licensing and wide application of new live attenuated rotavirus vaccines.

show abstract

Section: Managementmentioning

confidence: 99%

Viral gastroenteritis

Desselberger¹,

Gray²

2009

Medicine

View full text Add to dashboard Cite

show abstract

“…Diarrhoea and vomiting may lead to serious dehydration and death if untreated. Treatment is mainly by oral or intravenous rehydration [3]. Repeated natural rotavirus infections build up protection against disease [4].…”

Section: Introductionmentioning

confidence: 99%

The paediatric burden of rotavirus disease in Europe

2006

Epidemiol. Infect.

View full text Add to dashboard Cite

Rotaviruses are a major cause of hospitalizations for acute gastroenteritis in developed countries. This review shows the burden of rotavirus disease in < 5-year-old children in Europe. An estimated 72,000-77,000 hospitalizations for community-acquired rotavirus disease occur annually in the 23 million under-fives living in the European Union (EU-25), with a median cost of Euro 1417 per case. Annual hospitalization incidence rates range from 0.3 to 11.9/1000 children < 5 years old (median 3/1000). The median proportion of hospital-acquired rotavirus disease among all cases of hospitalization for rotavirus disease is estimated to be 21%. Countries of the EU-25 require information on the burden of rotavirus disease to support introduction of rotavirus vaccines. Data on cases treated at home, medical visits, and emergency wards as well as rotavirus-associated deaths are limited. To fully evaluate the impact and effectiveness of rotavirus vaccination programmes in Europe, additional epidemiological studies will be critical and desirable.

show abstract